0000000000511406

AUTHOR

M. Koch

showing 7 related works from this author

Soil mutagens are airborne mutagens: variation of mutagenic activities induced in Salmonella typhimurium TA 98 and TA 100 by organic extracts of agri…

2000

As our hypothesis was that soil mutagens are airborne mutagens, possibly modified by soil microorganisms, we checked solvent extracts from agricultural and forest soils collected during late summer in the environment of Mainz, a region highly charged by anthropogenic air pollution, or near Bayreuth, a rural low charged region of Germany, or in a remote region of western Corsica without anthropogenic air pollution for the presence of mutagenicity in Salmonella typhimurium. Levels of mutagenic activities were quantified by calculation of revertants/g from the initial slope of dose-response curves applying tester strains S. typhimurium TA 98 and TA 100 in the absence and presence of an activat…

PollutionSalmonella typhimuriumMethylnitronitrosoguanidineHealth Toxicology and Mutagenesismedia_common.quotation_subjectMutagenmedicine.disease_causecomplex mixturesAmes testTreesSoilGermanyGeneticsmedicineBenzo(a)pyreneAnimalsSoil PollutantsOrganic matterBiotransformationmedia_commonPollutantchemistry.chemical_classificationAir PollutantsGeographyChemistryEcologyfood and beveragesAgricultureSoil contaminationRatsEnvironmental chemistrySoil waterMicrosomes LiverComposition (visual arts)FranceSeasonsMutagensMutation research
researchProduct

Endoscopic treatment of gastroesophageal reflux disease.

2005

Gastroesophageal reflux disease is a common chronic disorder which has a severe effect on the patient's quality of life. In view of the high cost of medical therapy and the limitations of surgery, a variety of endoscopic techniques have been developed for the treatment of this condition, and these have shown apparently encouraging results, at least in the short term. However, promising results have been obtained in only around two-thirds of patients over a short-term follow-up period of about 6 months. Moreover, several inconsistencies have emerged between the efficacy of this form of treatment in improving symptoms and quality of life and a lack of improvement of objective parameters, such…

medicine.medical_specialtyDiseaseEndoscopy GastrointestinalREFLUX DISEASE TREATMENTQuality of life (healthcare)medicineHumansPolymethyl MethacrylateIntensive care medicinemedicine.diagnostic_testEsophageal diseasebusiness.industrySuture TechniquesGastroenterologyRefluxmedicine.diseaseChronic disordersMicrospheresEndoscopySurgeryClinical trialCatheter AblationGastroesophageal RefluxPolyvinylsbusinessEndoscopic treatmentEndoscopy
researchProduct

DEPFET Active Pixel Detectors for a Future Linear e(+)e(-) Collider

2013

arXiv:1212.2160v1.-- et al.

Vertex (graph theory)Nuclear and High Energy PhysicsParticle physicsPhysics - Instrumentation and DetectorsPhysics::Instrumentation and Detectorsvertex detectorComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONFOS: Physical sciences01 natural sciencesHigh Energy Physics - Experimentlaw.inventionHigh Energy Physics - Experiment (hep-ex)Signal-to-noise ratiolaw0103 physical sciencesElectrical and Electronic EngineeringDetectors and Experimental Techniques010306 general physicsColliderPrecision Pixel Detectors [9.3]ComputingMethodologies_COMPUTERGRAPHICSAdvanced infrastructures for detector R&D [9]PhysicsPixel010308 nuclear & particles physicsDetectorFísicaInstrumentation and Detectors (physics.ins-det)Active pixel sensorNuclear Energy and EngineeringHigh Energy Physics::ExperimentVertex detectorlinear colliderddc:620DEPFETPixel detector
researchProduct

Letaler Verlauf einer Meningokokkensepsis?das Waterhouse-Friderichsen-Syndrom

2004

Wir berichten uber einen 59-jahrigen Patienten, der nach unspezifischem Infekt der oberen Atemwege somnolent und hochfiebernd in unserer Klinik aufgenommen wurde. Innerhalb von Stunden entwickelte sich ein Waterhouse-Friderichsen-Syndrom als Sonderform der Meningokokkensepsis. Bei Auftreten von septischem Schock und disseminierter intravasaler Gerinnung verlauft die Krankheit trotz maximaler intensivmedizinischer Therapie in 85 –90% letal. Entscheidend fur einen Therapieerfolg sind die fruhestmogliche Diagnosestellung und die fruhzeitige Antibiotikagabe. Enge Kontaktpersonen sollten umgehend eine Antibiotikaprophylaxe erhalten.

Gynecologymedicine.medical_specialtybusiness.industryEmergency MedicineMedicineEmergency NursingCritical Care and Intensive Care MedicinebusinessIntensivmedizin und Notfallmedizin
researchProduct

Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

1991

Cancer Researchmedicine.medical_specialtyOncologybusiness.industrymedicineGeneral MedicineDrug resistancePharmacologyIntensive care medicinebusinessJournal of Cancer Research and Clinical Oncology
researchProduct

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver …

2015

In many countries, first-generation protease inhibitors (PIs)/peginterferon/ribavirin (P/R) still represent the only treatment option for HCV-infected patients. Subjects with advanced disease and previous failure to P/R urgently need therapy, but they are under-represented in clinical trials. All treatment-experienced F3/4 Metavir patients who received boceprevir (BOC)+P/R in the Italian-Spanish Name Patient Program have been included in this study. Multivariate logistic regression analysis (MLR) was used to identify baseline and on-treatment predictors of SVR and adverse events (AEs). Four hundred and sixteen patients, mean age 57.7 (range 25-78 years), 70% males, 69.5% (289/416) F4, 14% (…

MaleSettore MED/09 - Medicina Internaboceprevir; cirrhosis; first-generation protease inhibitors; hepatitis C; IFN-based therapy; Adult; Aged; Antiviral Agents; Drug Therapy Combination; Female; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Italy; Male; Middle Aged; Proline; RNA Viral; Ribavirin; Spain; Treatment Outcome; Viral Load; Hepatology; Infectious Diseases; Virology; Medicine (all)Hepacivirusboceprevir; cirrhosis; first-generation protease inhibitors; hepatitis C; IFN-based therapy; Adult; Aged; Antiviral Agents; Drug Therapy Combination; Female; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Italy; Male; Middle Aged; Proline; RNA Viral; Ribavirin; Spain; Treatment Outcome; Viral Load; Hepatology; Virology; Infectious DiseasesGastroenterologyIFN-based therapy; boceprevir; cirrhosis; first-generation protease inhibitors; hepatitis Cfirst-generation protease inhibitorchemistry.chemical_compoundLiver diseaseboceprevirMedicineViralChronicSettore MED/12 - Gastroenterologiaboceprevir; cirrhosis; first-generation protease inhibitors; hepatitis C; IFN-based therapy; Adult; Aged; Antiviral Agents; Drug Therapy; Combination; Female; Hepacivirus; Hepatitis C; Chronic; Humans; Interferon-alpha; Italy; Male; Middle Aged; Proline; RNA; Viral; Ribavirin; Spain; Treatment Outcome; Viral Load; Hepatology; Infectious Diseases; Virology; Medicine (all)Medicine (all)virus diseasesHepatitis CMiddle AgedViral LoadSettore MED/07 - Microbiologia e Microbiologia ClinicaHepatitis CInfectious DiseasesTreatment OutcomeItalyHCVCombinationRNA ViralDrug Therapy CombinationFemaleViral loadHumanAdultmedicine.medical_specialtyProlineAlpha interferonInfectious DiseaseAntiviral AgentsDrug TherapyVirologyInternal medicineBoceprevirRibavirinboceprevir; cirrhosis; first-generation protease inhibitors; hepatitis c; IFN-based therapy; adult; aged; antiviral agents; drug therapy combination; female; hepacivirus; hepatitis c chronic; humans; interferon-alpha; italy; male; middle aged; proline; RNA viral; ribavirin; spain; treatment outcome; viral load; hepatology; infectious diseases; virologyHumansDecompensationAdverse effectAgedAntiviral AgentIFN-based therapyHepaciviruHepatologybusiness.industryRibavirincirrhosisInterferon-alphaHepatitis C Chronicmedicine.diseasedigestive system diseasesboceprevir; cirrhosis; first-generation protease inhibitors; hepatitis C; IFN-based therapy; Adult; Aged; Antiviral Agents; Drug Therapy Combination; Female; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Italy; Male; Middle Aged; Proline; RNA Viral; Ribavirin; Spain; Treatment Outcome; Viral Loadfirst-generation protease inhibitorschemistrySpainImmunologyRNAbusinesscirrhosi
researchProduct

EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP…

2014

Background and Aims: To maximize cost/efficay of boceprevirbased triple therapy (BOC) in patients with HCV-related advanced fibrosis/cirrhosis. Methods: ITT SVR12, safety and futility rules value were evaluated in the multicenter national Italian and Spanish early access Name- Patient-Program which includes treatment-experienced patients with HCVG1-related advanced fibrosis/cirrhosis (Metavir F3/4) treated with BOC in both countries. Results: 402 patients (mean age 55 years; range 22–75), 316 (78.6%) G1b, 255 (63.4%) F4, 60 (30.9%) with oesophageal varices, 137 (34.1%) relapsers, 95 (23.6%) partial and 168 (41.8%) null responders were enrolled. Platelets count <100,000 and albumin levels <3…

CHRONIC HCVSettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaHEPATITIS CCIRRHOSISHEPATITIS C; CIRRHOSIS; CHRONIC HCV
researchProduct